Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,646 | 281 | 86.5% |
| Travel and Lodging | $933.35 | 4 | 12.2% |
| Education | $100.33 | 5 | 1.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic Vascular, Inc. | $2,271 | 17 | $0 (2020) |
| Medtronic, Inc. | $1,310 | 11 | $0 (2024) |
| Amgen Inc. | $967.35 | 76 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $352.91 | 21 | $0 (2024) |
| Abbott Laboratories | $322.05 | 7 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $269.90 | 17 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $264.41 | 16 | $0 (2019) |
| Merck Sharp & Dohme LLC | $249.79 | 18 | $0 (2024) |
| Gilead Sciences, Inc. | $233.06 | 19 | $0 (2019) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $231.28 | 16 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $708.55 | 32 | Medtronic, Inc. ($204.91) |
| 2023 | $901.91 | 25 | Medtronic, Inc. ($518.28) |
| 2022 | $766.12 | 32 | Medtronic, Inc. ($386.58) |
| 2021 | $591.85 | 33 | Medtronic, Inc. ($199.80) |
| 2020 | $695.20 | 36 | Medtronic Vascular, Inc. ($196.05) |
| 2019 | $705.65 | 29 | Medtronic Vascular, Inc. ($297.31) |
| 2018 | $2,345 | 54 | Medtronic Vascular, Inc. ($1,707) |
| 2017 | $964.92 | 49 | Amgen Inc. ($247.25) |
All Payment Transactions
290 individual payment records from CMS Open Payments — Page 1 of 12
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 11/18/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/30/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/24/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $16.54 | General |
| Category: Cardiology | ||||||
| 09/09/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Cardiology | ||||||
| 08/13/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $14.57 | General |
| Category: Cardiovascular | ||||||
| 08/12/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $15.58 | General |
| Category: Cardiology | ||||||
| 08/03/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $106.42 | General |
| Category: Pacemakers | ||||||
| 08/01/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $14.42 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 07/31/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $13.47 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/18/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: DIABETES | ||||||
| 06/27/2024 | LANTHEUS MEDICAL IMAGING, INC. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: CONTRAST AGENT | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $23.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/19/2024 | HEARTFLOW, INC. | FFRct (Device) | Food and Beverage | Cash or cash equivalent | $21.33 | General |
| Category: Coronary | ||||||
| 06/18/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $24.29 | General |
| Category: Medical Device | ||||||
| 06/12/2024 | Kiniksa Pharmaceuticals International, plc | Arcalyst (Drug) | Food and Beverage | In-kind items and services | $16.20 | General |
| Category: Not Applicable | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/01/2024 | Medtronic, Inc. | MICRA (Device) | Food and Beverage | In-kind items and services | $98.49 | General |
| Category: Pacemakers | ||||||
| 05/16/2024 | Boston Scientific Corporation | — | Food and Beverage | In-kind items and services | $30.05 | General |
| 05/07/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.22 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/06/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $15.44 | General |
| Category: Cardiovascular | ||||||
| 05/02/2024 | Merck Sharp & Dohme LLC | — | Food and Beverage | In-kind items and services | $16.40 | General |
| 03/07/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/20/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: RESPIRATORY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,428 | 2,244 | $518,355 | $124,323 |
| 2022 | 21 | 1,554 | 2,526 | $590,170 | $141,172 |
| 2021 | 22 | 1,833 | 2,946 | $708,095 | $174,178 |
| 2020 | 21 | 1,876 | 3,067 | $784,955 | $188,581 |
All Medicare Procedures & Services
85 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 286 | 548 | $233,085 | $53,772 | 23.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 91 | 122 | $72,590 | $17,374 | 23.9% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 64 | 162 | $37,260 | $10,843 | 29.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 148 | 153 | $37,245 | $8,386 | 22.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 326 | 695 | $34,720 | $8,213 | 23.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 56 | 61 | $26,230 | $6,114 | 23.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 55 | $16,500 | $3,862 | 23.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $15,030 | $3,816 | 25.4% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2023 | 48 | 48 | $12,000 | $3,041 | 25.3% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 24 | $7,800 | $2,442 | 31.3% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 13 | $8,190 | $1,782 | 21.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 180 | 194 | $5,820 | $1,336 | 22.9% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 25 | 31 | $3,875 | $1,314 | 33.9% |
| 93288 | Evaluation of single, dual, multiple lead or leadless pacemaker system | Office | 2023 | 13 | 15 | $3,075 | $775.35 | 25.2% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Facility | 2023 | 58 | 59 | $2,950 | $662.48 | 22.5% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 17 | 22 | $1,760 | $463.76 | 26.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 13 | 15 | $225.00 | $126.00 | 56.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 305 | 558 | $237,815 | $53,828 | 22.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 134 | 192 | $114,540 | $27,300 | 23.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 166 | 177 | $41,365 | $10,371 | 25.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 328 | 736 | $37,035 | $8,386 | 22.6% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 54 | 130 | $29,940 | $7,941 | 26.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 13 | 24 | $16,560 | $4,486 | 27.1% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Facility | 2022 | 66 | 67 | $18,105 | $4,404 | 24.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 21 | 46 | $15,010 | $3,967 | 26.4% |
About Ebrahim Issa
Ebrahim Issa is a Specialist healthcare provider based in Teaneck, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2006. The National Provider Identifier (NPI) number assigned to this provider is 1578524864.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Ebrahim Issa has received a total of $7,680 in payments from pharmaceutical and medical device companies, with $708.55 received in 2024. These payments were reported across 290 transactions from 32 companies. The most common payment nature is "Food and Beverage" ($6,646).
As a Medicare-enrolled provider, Issa has provided services to 6,691 Medicare beneficiaries, totaling 10,783 services with total Medicare billing of $628,254. Data is available for 4 years (2020–2023), covering 85 distinct procedure/service records.
Practice Information
- Specialty Specialist
- Location Teaneck, NJ
- Active Since 03/28/2006
- Last Updated 10/07/2013
- Taxonomy Code 174400000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1578524864
Products in Payments
- Reveal LINQ (Device) $1,138
- MICRA (Device) $723.19
- Repatha (Biological) $698.55
- PRALUENT (Drug) $251.69
- Corlanor (Drug) $243.46
- VERQUVO (Drug) $233.39
- XARELTO (Drug) $209.93
- CareLink (Device) $199.80
- MYCARELINK (Device) $175.18
- PRADAXA (Drug) $159.89
- ELIQUIS (Drug) $148.82
- ENTRESTO (Drug) $147.88
- Ranexa (Drug) $139.39
- Confirm Rx (Device) $129.43
- FARXIGA (Drug) $124.61
- LEQVIO (Drug) $122.02
- Lexiscan (Drug) $120.00
- LINQ II (Device) $117.59
- BRILINTA (Drug) $102.53
- WATCHMAN (Device) $101.96
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Specialist Doctors in Teaneck
Dr. Peter Hersh, M.d, M.D
Specialist — Payments: $72,201
Adam Palance, Md, MD
Specialist — Payments: $11,766
Dr. Christopher Brown, M.d, M.D
Specialist — Payments: $5,561
Philip Micale, M.d, M.D
Specialist — Payments: $4,402
Dr. Payal Shah
Specialist — Payments: $3,938
Michael Schmidt, Md, MD
Specialist — Payments: $3,036